<DOC>
	<DOC>NCT01044316</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of two doses of two commercially available vaccines used to prevent Haemophilus influenzae type b infections in children 6-12 months of age.</brief_summary>
	<brief_title>Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in China</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<criteria>Infants 612 months of age. Prior Hib vaccine administration. History of serious reaction(s) following vaccination. Any vaccination within 14 days of study vaccination. Known or suspected immune impairment. For additional entry criteria please refer to the protocol.</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Haemophilus influenzae type b (Hib)</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Booster</keyword>
</DOC>